Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease

NCT00462254 is registered in ClinicalTrials.gov with Southern California Institute for Research and Education as lead sponsor.

NCT NCT00462254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
Lead sponsor
Southern California Institute for Research and Education
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2007
Completion date
June 30, 2008
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease